AGENUS INC Intangible Assets, Net (Excluding Goodwill)
AGENUS INC (AGEN) had Intangible Assets, Net (Excluding Goodwill) of $2.88 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2026-08-07
- 2026-06-30: Intangible Assets, Net (Excluding Goodwill) $2.88M.
- 2026-03-31: Intangible Assets, Net (Excluding Goodwill) $2.96M.
- 2025-12-31: Intangible Assets, Net (Excluding Goodwill) $3.04M.
- 2025-09-30: Intangible Assets, Net (Excluding Goodwill) $3.12M.
| Period end | Intangible Assets, Net (Excluding Goodwill) | Intangible Assets, Net (Excluding Goodwill) as first filed |
|---|---|---|
| 2026-06-30 | $2.88M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $2.96M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $3.04M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $3.12M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $3.21M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $3.29M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $3.38M 10-K · filed 2026-03-16 | |
| 2024-09-30 | $3.96M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $4.14M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $4.23M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $4.41M 10-K · filed 2025-03-17 | |
| 2023-09-30 | $4.50M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $4.99M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $5.66M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $6.23M 10-K · filed 2024-03-14 | |
| 2022-09-30 | $6.88M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $7.72M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $7.75M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $8.49M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $8.99M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $9.59M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $9.99M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $10.89M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $11.15M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $11.76M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $10.05M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $10.50M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $10.85M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $11.42M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $11.81M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $12.34M 10-K · filed 2020-03-16 | $12.34M 10-K · filed 2019-03-18 |
| 2018-09-30 | $12.83M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $13.28M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $13.97M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $14.41M 10-K · filed 2019-03-18 | |
| 2017-09-30 | $14.93M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $15.59M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $15.91M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $16.36M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $17.22M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $17.72M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $18.39M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $18.76M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $6.49M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $6.89M 10-Q · filed 2015-08-03 | |
| 2015-03-31 | $6.82M 10-Q · filed 2015-05-01 | |
| 2014-12-31 | $6.77M 10-K · filed 2016-03-15 | |
| 2014-09-30 | $7.18M 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $7.81M 10-Q · filed 2014-08-01 | |
| 2014-03-31 | $8.00M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $0.00 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |